阿爾特(300825.SZ):目前已為近百家客户成功研發超500款車型
格隆匯7月25日丨阿爾特(300825.SZ)近日在接待機構投資者調研時表示,公司是行業領先的提供獨立整車研發及系統解決方案的前瞻技術驅動型企業,業務已覆蓋產品定義、造型設計、工程設計、軟件開發等整車研發全產業鏈,目前已為近百家客户成功研發超500款車型。公司客户涵蓋國內主要汽車生產企業、國際知名品牌和眾多造車新勢力,代表車型包括東風本田e:NS1、廣汽本田e:NP1、一汽大眾捷達、一汽紅旗H5、嵐圖夢想家、小鵬G3、合眾哪吒U等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.